1. Home
  2. LESL vs BLRX Comparison

LESL vs BLRX Comparison

Compare LESL & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leslie's Inc.

LESL

Leslie's Inc.

N/A

Current Price

$0.23

Market Cap

12.4M

Sector

Miscellaneous

ML Signal

N/A

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

N/A

Current Price

$2.43

Market Cap

12.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LESL
BLRX
Founded
1963
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.4M
12.0M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
LESL
BLRX
Price
$0.23
$2.43
Analyst Decision
Hold
Strong Buy
Analyst Count
6
2
Target Price
$2.54
★ $19.00
AVG Volume (30 Days)
★ 703.3K
19.3K
Earning Date
05-18-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,241,915,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.62
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.25
$2.15
52 Week High
$12.53
$4.56

Technical Indicators

Market Signals
Indicator
LESL
BLRX
Relative Strength Index (RSI) 22.51 41.19
Support Level N/A $2.18
Resistance Level $0.59 $2.51
Average True Range (ATR) 0.06 0.11
MACD 0.05 0.00
Stochastic Oscillator 4.46 0.00

Price Performance

Historical Comparison
LESL
BLRX

About LESL Leslie's Inc.

Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products, including chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company serves residential pool, residential spa, professional pool, and commercial pool consumers and markets its products through over 1,000 company-operated locations in 39 states and e-commerce websites, operating only in the United States. It operates mainly in the pool and spa aftermarket industry and offers regularly purchased, non-discretionary maintenance items, along with installation and repair services for pool and spa equipment.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: